Analgesic/abortive overuse and misuse in chronic daily headache

被引：24

作者：

Diener H.-C. ^{[1
]}

Katasarva Z. ^{[1
]}

机构：

[1] Department of Neurology, University Essen, Hufelandstr. 55, Essen

来源：

Current Pain and Headache Reports | 2001年 / 5卷 / 6期

关键词：

Chronic Daily Headache; Migraine; Migraine Attack; Sumatriptan; Zolmitriptan;

D O I：

10.1007/s11916-001-0061-7

中图分类号：

学科分类号：

摘要：

The frequent use (> 15 times/month) of medication for the treatment of acute migraine attacks may cause medication overuse headache. This kind of headache can be caused by the intake of combination analgesics, opioids, ergot alkaloids, and triptans. The delay between first intake and daily headache is shortest for triptans (1 to 2 years), longer for ergots (3 years), and longest for analgesics (5 years). Treatment includes drug withdrawal followed by structured acute therapy and initiation of migraine prophylactic treatment. © 2001, Current Science Inc.

引用

页码：545 / 550

页数：5

共 46 条

[1]

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society, Cephalalgia, 8, pp. 1-93, (1988)

[2]

Castillo J., Munoz P., Guitera V., Pascual J., Epidemiology of chronic daily headache in the general population, Headache, 39, pp. 190-196, (1999)

[3]

Granella F., Farina S., Malferrari G., Manzoni G.C., Drug abuse in chronic headache: a clinico-epidemiologic study, Cephalalgia, 7, pp. 15-19, (1987)

[4]

Micieli G., Manzoni G.C., Granella F., Et al., Clinical and epidemiological observations on drug abuse in headache patients, Drug-induced Headache., pp. 20-28, (1988)

[5]

Rapoport A., Stang P., Gutterman D.L., Et al., Analgesic rebound headache in clinical practice: data from a physician survey, Headache, 36, pp. 14-19, (1996)

[6]

Gaist D., Tsiropoulus I., Sindrup S.H., Et al., Inappropriate use of sumatriptan: population based register and interview study, Br J Med, 316, pp. 1352-1353, (1998)

[7]

Gaist D., Use and overuse of sumatriptan. Pharmaco-epidemiological studies based on prescription register and interview data, Cephalalgia, 19, pp. 735-761, (1999)

[8]

Evers S., Gralow I., Bauer B., Et al., Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study, Clin Neuropharmacol, 22, pp. 201-206, (1999)

[9]

Mihatsch M.J., Knusli C., Phenacetin abuse and malignant tumors, Klin Wochenschr, 60, pp. 1339-1349, (1982)

[10]

Mihatsch M.J., Hofer H.O., Gudat F., Et al., Capillary sclerosis of the urinary tract and analgesic nephropathy, Clin Nephrol, 20, pp. 285-301, (1983)

← 1 2 3 4 5 →